BRAF polymorphisms and the risk of ovarian cancer of low malignant potential.
Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, McGurie V, DiCioccio RA, Duffy D, Chenevix-Trench G.
Kelemen L, et al.
Gynecol Oncol. 2005 Jun;97(3):807-12. doi: 10.1016/j.ygyno.2005.03.007.
Gynecol Oncol. 2005.
PMID: 15904951